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Abstract
Sequences of the novel gammaretrovirus, xenotropic murine leukemia virus-related virus (XMRV) have been described in
human prostate cancer tissue, although the amounts of DNA are low. Furthermore, XMRV sequences and polytropic (p)
murine leukemia viruses (MLVs) have been reported in patients with chronic fatigue syndrome (CFS). In assessing the
prevalence of XMRV in prostate cancer tissue samples we discovered that eluates from naı¨ve DNA purification columns,
when subjected to PCR with primers designed to detect genomic mouse DNA contamination, occasionally gave rise to
amplification products. Further PCR analysis, using primers to detect XMRV, revealed sequences derived from XMRV and
pMLVs from mouse and human DNA and DNA of unspecified origin. Thus, DNA purification columns can present problems
when used to detect minute amounts of DNA targets by highly sensitive amplification techniques.
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Introduction
Murine endogenous retroviruses are categorised on the basis of
their receptor usage and tropism and include xenotropic (x)
murine leukemia viruses (MLVs) and polytropic (p) MLVs. The
gammaretrovirus, xenotropic murine leukemia virus-related virus
(XMRV) was first described in cases of human prostate cancer
[1,2] and chronic fatigue syndrome (CFS) [3]. Like XMRV,
pMLVs sequences have been found in blood samples from CFS
patients [4]. However, these findings have been challenged by
others [5–16]. Reports describing the identification of XMRV in
human tissue have also highlighted the fact that XMRV detection
by PCR is unreliable and suggested that the low proviral DNA
copy number accounts for this. Another explanation, however
could be the detection of contaminating DNA rather than a
genuine virus infection. Despite its genetic similarity to xMLVs
[1], XMRV has no reservoir in mice [17], but several copies of the
virus are present in the human prostate cancer cell line, 22Rv1,
which releases infectious virus particles [18]. It has been proposed
that XMRV was generated in the 1990s from a unique
recombination event between two murine endogenous proviruses
when the 22Rv1 cell line was being established, a process that
involved repeated passages through nude mice [17]. The authors
also point out that since it is highly unlikely that a similar
recombination event occurred elsewhere by random chance, then
all XMRV isolates of similar sequence owe their provenance to
this event and, hence, there is no natural human reservoir of
XMRV.
Detection of XMRV and other MLV-related viruses, generally
rely on PCR amplification of integrated proviral DNA sequences.
It is, therefore, a source of concern that several XMRV
publications have described the ease with which samples can be
contaminated with murine DNA [19–22]. One highly sensitive
way to distinguish between mouse and murine retroviral DNA is to
look for intracisternal A particle (IAP) sequences, retrotransposons
present at about 1,000 copies per mouse genome [23].
Analysis
Detection of Murine DNA in FFPE Columns
Using Qiagen’s QIAamp DNA FFPE Tissue Kit (Qiagen,
Crawley, UK) as directed in the manufacturer’s instructions, we
recently observed that DNA extracted from formalin-fixed
paraffin-embedded (FFPE) prostate cancer tissue from the UK,
Thailand and Korea (supplied from non commercial sources as
detailed in [19]), occasionally contained mouse DNA. This murine
contamination was detected by PCR using primers IAP forward
and IAP reverse (Table 1), specifically designed to amplify IAP
sequences. We used TaqGold polymerase (Applied Biosystems,
Warrington, UK) for the PCR under described conditions [19].
Sequences for IAP were obtained from elution buffer processed
through several empty (control) columns used directly as supplied
by Qiagen. Multiple PCR water controls (not processed through
the columns) were consistently negative, indicating that the PCR
buffers and polymerase enzyme used in the PCR were clean and
that mouse contamination had not been introduced during the
reaction (data not shown).
It was not possible to determine if the kit buffers were
contaminated with mouse DNA, as they inhibited the IAP PCR
when they were added to the positive control, namely DNA from
McCoy murine fibroblast cell line (ECACC #90010305), (data
not shown). To investigate the prevalence of murine DNA signals
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in FFPE columns we looked at a total of 68 ‘‘mock-extracted’’
column eluates following manufacturer’s instructions, but without
adding any tissue sample. We detected signals for IAP in 11 of
these 68 columns assayed (16.1%) (Fig. 1, upper panel and data
not shown). The PCR product shown in Fig. 1, lane 10 was cloned
into plasmid pPCR4TOPO (Invitrogen, Paisley, UK), sequenced
and identified as IAP.
Detection of XMRV and pMLV Sequences in FFPE
Columns
As recently described [19] DNA extracted from IAP positive
prostate cancer tissue occasionally also gave rise to pMLV
sequences and XMRV-specific PCR products, the latter defined
by the 24 bp deletion in the leader/gag region of XMRV [19].
When nested PCR was carried out on the eluate of the 11 IAP-
positive mock-extracted columns, a fragment with a sequence
identical to XMRV was amplified from one of them. The nested
PCR conditions to detect XMRV sequences have been docu-
mented [7]. First-round reaction conditions were the same as
described for the amplification of IAP sequences, but with primers
XMRV Forward outer and XMRV Reverse outer (Table 1). In
order to clone and sequence the PCR product, the second round
again made use of the XMRV Forward outer and XMRV Reverse
outer primers, as these bind outside the XMRV-specific 24 bp
deletion. The XMRV infectious clone, VP62 plasmid DNA,
constituted the positive control. Using less stringent annealing
conditions (50uC instead of 55uC), a PCR with primers XTP1 and
MLV reverse outer, which targets the XMRV gag/pro/pol open
reading frame (ORF), amplified further products (Fig. 1, middle
panel). Under the same conditions, a multiplex PCR with the four
primers XMRV-R, XMRV Forward outer, XMRV Reverse outer
and 1154R (Table 1) that bind to the long terminal repeat, the
leader/gag sequence and the gag ORF, also produced various
amplicons (Fig. 1, lower panel). Using published primers to the
XMRV env region [3], three out of ten columns tested produced
an amplification product (not shown). At least four ‘‘no template’’
water controls were included in each experiment.
Several of these amplicons were cloned and sequenced. A
GenBank database search indicated contaminating sequences of
human and murine origin. These included two leader/gag regions
Table 1. DNA primer sequences.
Name Sequence Position *
XMRV Forward outer 59 CATTCTGTATCAGTTAACCTAC 39 411–432
XMRV Reverse outer 59 ATGATCTCGAGAACACTTAAAG 39 588–609
XMRV Forward inner 59 GACTTTTTGGAGTGGCTTTGT 39 411–461
XMRV Reverse inner 59 ACAGAAGAACAACAAAACAAATC 39 544–566
XMRV-R 59 GGGCCAGTCATCCGATAGACT 39 8109–8129
XTP1 59 CACCCACTCTTTCCTCCATGT 39 2437–2457
MLV reverse outer 59 CATCAAACAGGGTGGGACTG 39 3160–3179
1154R 59 GCCGCCTCTTCTTCATTGTTCTC 39 1127–1149
5922F 59 GCTAATGCTACCTCCCTCCTGG 3 9 5917–5938
6273R 59 GGAGCCCACTGAGGAATCAAAACAGG 39 6242–6267
IAP forward 59 ATAATCTGCGCATGAGCCAAGG 39
IAP reverse 59 AGGAAGAACACCACAGACCAGA 39
IAP PROBE 59 FAM-ATGGGCTGCAGCCAATCAGGGAGTGAT-TAMRA 39
*GenBank accession no. EF185282.1.
doi:10.1371/journal.pone.0023484.t001
Figure 1. Amplification of contaminating DNA from empty
columns of the QiaAmp FFPE Tissue Kit. Lanes 1–10, naı¨ve DNA
extraction columns; lanes 11–14, PCR water controls; lane 15, positive
control; upper panel, McCoy cellular DNA; middle and lower panel,
XMRV VP62 infectious clone; lane 16, 100 bp DNA ladder (Invitrogen,
Paisley, UK). Upper panel, detection of contaminating sequences using
IAP-specific primers IAP for and IAP rev. All columns apart from column
no 7 produce amplicons. Size differences reflect the fact that IAP
sequences form a class of slightly different retrotransposons. Middle
panel, PCR products using primers XTP1 and MLV reverse outer under
relaxed annealing conditions. Lower panel, multiplex PCR using the four
primers XMRV-R, XMRV Forward outer, XMRV Reverse outer and 1154R
under less stringent annealing conditions.
doi:10.1371/journal.pone.0023484.g001
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displaying the 24 nt deletion described for XMRV (one sequence
being identical, one having two mismatches and a 1 bp insertion,
respectively), five leader/gag regions of pMLVs, all displaying a
9 bp deletion, one gag/pol ORF of pMLV or XMRV (8
mismatches and 10 mismatches out of 599 bp, respectively), and
one sequence of the env gene of a murine enogenous polytropic
retrovirus. In addition one DNA sequence had homology to mouse
chromosome 11, two other DNA sequences showed homology to
human chromosome 6 and 10. Two further sequences were of
unspecified origin. Although these were not mapped to any
particular gene, they are nevertheless an indication of contami-
nating DNA from a variety of sources. Alignments of leader/gag
and env sequences obtained from the columns and VP62, the
reference XMRV infectious clone (GenBank accession no.
EF185282.1), are shown in Fig. 2.
Detection of Murine DNA in Other Columns
Columns of the QIAamp DNA Mini Kit were also mock-
extracted as described in the manufacturer’s instructions, but no
IAP sequences were identified in the eluate. In a further
experiment, carried out by a different operator in a separate
laboratory, a column from the QiaAmp DNA Investigator Kit was
dismantled. After soaking the DNA binding membrane in elution
buffer overnight, samples of this elution buffer were amplified in a
real time PCR (RT-PCR) specific for IAP. The RT-PCR was
carried out using the Quantitect probe kit (Qiagen, UK) as per
manufacturer’s instructions, using the primers and probes
described in Table 1. Reactions were in volumes of 10ml to which
2.5ml eluate was added and were amplified in a Biorad CFX96
thermal cycler. Qiagen 2x Quantitect probe mastermix was used
(Qiagen, UK) with 2.5 pmol of each primer IAP for and IAP rev.
In addition, 2.5 pmol IAP PROBE was added to each reaction.
Cycling conditions were one cycle of 95uC 15 seconds followed by
60 cycles of 94uC 15 seconds, 60uC 15 seconds. As a positive
control, DNA from McCoy cells was used. At least 6 ‘‘no
template’’ controls were set up in each RT-PCR. The control
sample of unexposed elution buffer remained negative, but an
IAP-specific signal from elution buffer exposed to the column
pieces was observed. Upon cloning, the sequence of the amplicon
was confirmed to be IAP (data not shown). It is worth noting that
QIAamp Ultraclean Production (UCP) Pathogen columns which
are certified to be free of contaminating microbial DNA yielded no
amplification product for IAP or MLV-related sequences in 50
‘‘mock-extracted’’ columns.
Discussion
There are many commercially available kits that rely on DNA
binding columns to extract and purify DNA from tissues or
cultured cells. Our observations by two different laboratory
investigators (OE and MJR) using three different kits and working
in separate laboratories, demonstrate that they can be contami-
nated with DNA of diverse provenance. This includes DNA from
mice. It cannot be ruled out that some of the buffers used during
Figure 2. Alignment of the infectious molecular clone of XMRV, VP 62, and sequences obtained from mock eluted columns. (A)
Alignment of the leader/gag region, displaying the XMRV specific deletion. (B) Alignment of the env region.
doi:10.1371/journal.pone.0023484.g002
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the DNA extraction process were contaminated and, in turn,
resulted in contamination of some of the columns. We tested the
elution buffers from several kits and found no evidence for
contamination. A confounding issue was the fact that tissue lysis
buffers and washing buffers in these kits were found to contain
substances that inhibited the PCR and, therefore, the buffers could
not be reliably tested. Therefore, it is possible that these buffers
contain traces of DNA which bind to the columns and are eluted
in later steps, contaminating the sample. However, it is telling that
dismantled column parts soaked in elution buffer resulted in an
IAP signal while the elution buffer control did not, suggesting that
the columns themselves can be contaminated.
Recently, several publications documented that widely used
PCR enzymes and buffers can be contaminated with murine DNA
[13,14,24]. Taken together with the data presented here, these
results may explain some of the spurious ‘‘detections’’ of XMRV
or related pMLV sequences [2], even in laboratories that use
neither mice nor XMRV-infected cell lines and avoid enzymes
known to contain traces of murine DNA. For those involved in
detecting minute amounts of retroviral sequences in human tissue,
these data may serve as a useful reminder to check reagents to
confirm that murine sequences are absent before analysing tissue
samples.
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